CNTX-6016

· Centrexion Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CNTX-6016, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN [Phase 1]